{"id":"cb7e1c59-a4d7-4cb3-8165-9df17f602d30","slug":"the-outcome-of-a-subdural-hematoma-after-embolization-of-the-middle-meningeal-artery-depends-on-many-influencing-factors","title":"The outcome of a subdural hematoma after embolization of the middle meningeal artery depends on many influencing factors","authors":["Josef Finsterer"],"abstract":"Background: The article discusses a study on the outcomes of 72 patients with chronic subdural hematoma (SDH) after initial surgical treatment, with a focus on those who underwent middle meningeal artery embolization (MMAE). The study found that 35.3% of patients who received MMAE experienced a recurrence requiring surgical intervention. Factors influencing recurrence rates were explored, including the timing of MMAE and the source of the hemorrhage. Summary: The authors raise several points regarding the limitations of the study, including the small sample size and the need for multicenter research to establish optimal timing for MMAE. They also highlight the importance of identifying the source of bleeding prior to embolization and the potential impact of SARS-CoV-2 infection on SDH outcomes. Additionally, they note the challenges in accurately counting SDH recurrences, as not all are clinically apparent. Conclusion: The authors suggest that the limitations of the study should be addressed to strengthen its conclusions. They emphasize the need for larger, multicenter studies to determine the appropriateness of MMAE as a treatment for chronic SDH, particularly given the significant recurrence rate observed. Keywords: subdural hematoma, embolization, middle meningeal artery, recurrence, SARS-CoV-2, treatment outcomes, limitations, multicenter studies","thumbnailUrl":"https://sni-digital-videos.s3.amazonaws.com/placeholders/specialty/neurovascular.png","publishDate":"2024-08-09T00:00:00.000Z","doi":"10.25259/SNI_587_2024","categories":["Neurovascular","Letter to the Editor"],"fullTextUrl":"https://surgicalneurologyint.com/wp-content/uploads/2024/08/13031/SNI-15-279.pdf"}